Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
2348.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
-15%
0.09
vs 0.11
Q4.20
+40%
0.11
vs 0.08
Q2.21
+45%
0.13
vs 0.09
Q4.21
+45%
0.15
vs 0.11
Q2.22
+1%
0.13
vs 0.13
Q4.22
-9%
0.14
vs 0.15
Q2.23
+38%
0.18
vs 0.13
Q4.23
-63%
0.05
vs 0.14
Q2.24
+91%
0.35
vs 0.18
Q4.24
-2%
0.05
vs 0.05
Sales Growth
YoY
Current
Estimates
Q2.20
0%
489M vs 490.8M
Q4.20
+17%
535.3M vs 459.3M
Q2.21
+24%
608.6M vs 489M
Q4.21
+4%
556.6M vs 535.3M
Q2.22
+2%
623.5M vs 608.6M
Q4.22
+18%
654.2M vs 556.6M
Q2.23
+4%
649.9M vs 623.5M
Q4.23
-23%
501.2M vs 654.2M
Q2.24
-11%
577.4M vs 649.9M
Q4.24
-4%
482.9M vs 501.2M
Return on Equity
QoQ
Q2.21
+8%
0.08
vs 0.06
Q4.21
+8%
0.08
vs 0.08
Q2.22
+7%
0.07
vs 0.08
Q4.22
+7%
0.07
vs 0.07
Q2.23
+9%
0.09
vs 0.07
Q4.23
+2%
0.02
vs 0.09
Q2.24
+15%
0.15
vs 0.02
Q4.24
+2%
0.02
vs 0.15
Institutionnal Ownership
Quote Panel
Key Metrics
Relative Strength
2348.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
HKSE
Relative Strenght
Volume Buzz
-81%
Earning Acce
No
Dist 52w H.
11%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 2348.HK compares to sector?